Abits Group Inc - Ordinary Shares (ABTS)

0.3186
-0.0077 (-2.36%)
NASDAQ · Last Trade: Nov 18th, 1:53 AM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Abits Group Signs Letter of Intent to Acquire Boston Solar, Advancing Vertically Integrated AI Infrastructure Strategy
Proposed acquisition would add an established solar energy business with engineering and installation capabilities to support Abits' AI infrastructure strategyIf the acquisition is completed, the Company intends to evaluate solar development opportunities at existing and future infrastructure sites to expand energy generation capabilities and reduce reliance on grid electricity
By Abits Group Inc. · Via ACCESS Newswire · November 17, 2026
Abits Group Highlights Existing Datacenter Infrastructure and 24 MW Power Capacity to Support AI and HPC Hosting Expansion Strategy
Existing Tennessee infrastructure potentially expandable to 34 MWProposed partner-funded model designed to launch initial AI hosting operations without additional debt financing
By Abits Group · Via ACCESS Newswire · November 5, 2026
Abits Group Announces AI Infrastructure and High-Performance Computing Expansion Strategy
Company to evaluate existing U.S. power infrastructure and data center operations for potential AI infrastructure hosting opportunities
By Abits Group Inc. · Via ACCESS Newswire · November 3, 2026
IGC Pharma’s (NYSE: IGC) CEO Appears on Bloomberg TV Discussing Alzheimer’s Fast-Acting IGC-AD1 Pharmaceutical Therapeutic – More Stocks Inside
IGC Pharma, Inc. (NYSE: IGC), a clinical-stage AI biotechnology company focused on Alzheimer’s disease, is gaining investor attention after CEO Ram Mukunda appeared on Bloomberg TV discussing the company’s lead drug candidate, IGC-AD1, a potential fast-acting therapy for agitation associated with Alzheimer’s dementia .
Via AB Newswire · June 1, 2026